ProGraME: A novel flow cytometry algorithm for the diagnosis of low-risk myelodysplastic syndromes in patients with cytopenia

Keyphrases

• Flow Cytometry 100%
• Cytopenia 100%
• Low-risk Myelodysplastic Syndromes 100%
• Training Population 66%
• Dysplasia 50%
• Bone Marrow Dysplasia 50%
• Monocytes 33%
• Granulocytes 33%
• Validation Cohort 33%
• Erythroid Precursors 33%
• High Risk 16%
• Low Risk 16%
• Diagnostic Assessment 16%
• Lymphocytes 16%
• Early Change 16%
• Negative Predictive Value 16%
• Side Scatter 16%
• Cell Lineage 16%
• Cluster of Differentiation 36 (CD36) 16%
• CD34+ Cells 16%
• CD33 16%
• Morphological Analysis 16%
• Myelodysplasia 16%
• Progenitor Cells 16%
• Minimal Requirements 16%
• Relevant Population 16%
• Molecular Assessment 16%
• Flow Injection Analysis 16%
• Combined Flow 16%
• Scattering Ratio 16%

Medicine and Dentistry

• Flow Cytometry 100%
• Cytopenia 100%
• Myelodysplastic Syndrome 100%
• Precursor 50%
• Dysplasia 50%
• Granulocyte 33%
• Monocyte 33%
• Diagnosis 16%
• Morphology 16%
• Lymphocyte 16%
• Flow Measurement 16%
• Progenitor Cell 16%
• Cell Lineage 16%

Immunology and Microbiology

• Precursor 100%
• Monocyte 66%
• Granulocyte 66%
• Morphology 33%
• Lymphocyte 33%
• CD34 33%
• CD33 33%
• CD36 33%
• Cell Lineage 33%